1.
2.
J Am Acad Dermatol
; 87(5): 1125-1127, 2022 11.
Article
in English
| MEDLINE
| ID: mdl-35131403
3.
Am J Med
; 134(11): e561-e562, 2021 11.
Article
in English
| MEDLINE
| ID: mdl-34270991
Subject(s)
Antibodies, Monoclonal, Humanized/adverse effects , Candida glabrata , Candidiasis, Invasive/etiology , Dermatologic Agents/adverse effects , Diabetes Mellitus, Type 2/drug therapy , Psoriasis/drug therapy , Pyelonephritis/etiology , Sepsis/etiology , Sodium-Glucose Transporter 2 Inhibitors/adverse effects , Benzhydryl Compounds/adverse effects , Candidiasis, Invasive/microbiology , Diabetes Mellitus, Type 2/complications , Female , Glucosides/adverse effects , Humans , Hypoglycemic Agents/therapeutic use , Insulin Detemir/therapeutic use , Liraglutide/therapeutic use , Middle Aged , Psoriasis/complications , Pyelonephritis/microbiology , Recurrence , Sepsis/microbiology , Urinary Tract Infections/etiology , Urinary Tract Infections/microbiology
4.
J Am Acad Dermatol
; 83(3): e205-e206, 2020 09.
Article
in English
| MEDLINE
| ID: mdl-32407739
5.